15 Biggest Mid-Day Gainers For Monday

Puma Biotechnology Inc (NASDAQ:PBYI) shares jumped 83.5 percent to $69.35 as briefing documents for Wednesday Advisory Committee meeting are published to the FDA website. The documents showed that neratinib performed better than Roche's trastuzumab in I-SPY2 trial, particularly in subgroup of patients that were HRc negative. The briefing docs also showed that study 3004 met prespecified primary efficacy endpoint.
Nutraceutical Int'l Corp. (NASDAQ:NUTR) shares surged 49.8 percent to $41.95 after the company agreed to be acquired by HGGC for $41.80 per share in cash.
Cheetah Mobile Inc (ADR) (NYSE:CMCM) shares gained 12.8 percent to $11.90 following strong earnings report.
Ferroglobe PLC (NASDAQ:GSM) shares surged 12.2 percent to $10.34 after the company posted a narrower-than-expected Q1 loss.
Nutanix Inc (NASDAQ:NTNX) jumped 11.4 percent to $17.83. Nutanix disclosed the private cloud deployment of SAIC Volkswagen. Goldman Sachs upgraded Nutanix from Neutral to Buy.
Radius Health Inc (NASDAQ:RDUS) shares climbed 10.4 percent to $38.55 likely on the heels of concerning adverse side effect data from Amgen on its osteoporosis treatment.
Oclaro, Inc. (NASDAQ:OCLR) shares gained 9 percent to $9.26.
Yirendai Ltd - ADR (NYSE:YRD) shares rose 7.4 percent to $25.78 following Q1 earnings report.
Blackstone Group LP (NYSE:BX) climbed 5.3 percent to $31.45. Citigroup upgraded Blackstone Group from Neutral to Buy.
Cree, Inc. (NASDAQ:CREE) rose 5.2 percent to $24.30. JMP Securities upgraded Cree from Market Perform to Market Outperform.
GNC Holdings Inc (NYSE:GNC) shares gained 4.7 percent to $7.62 following announcement of Nutraceutical acquisition.
Booz Allen Hamilton Holding Corporation (NYSE:BAH) climbed 4.5 percent to $37.56 as the company posted better-than-expected results for its fourth quarter.
Ciena Corporation (NYSE:CIEN) shares rose 4.1 percent to $23.89. Stifel Nicolaus upgraded Ciena from Hold to Buy.
Genesco Inc. (NYSE:GCO) shares surged 3.4 percent to $46.60. B. Riley upgraded Genesco Inc from Neutral to Buy.
Carvana Co (NYSE:CVNA) rose 3.3 percent to $11.77. Craig-Hallum initiated coverage on Carvana with a Buy rating.